Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
Dominelli F, Zingaropoli MA, Tartaglia M, Tortellini E, Guardiani M, Perri V, Pasculli P, Ciccone F, Malimpensa L, Baione V, Napoli A, Gaeta A, Lichtner M, Conte A, Mastroianni CM, Ciardi MR.
Dominelli F, et al. Among authors: tartaglia m.
Front Immunol. 2022 Dec 1;13:1050183. doi: 10.3389/fimmu.2022.1050183. eCollection 2022.
Front Immunol. 2022.
PMID: 36532061
Free PMC article.